THE INNOVATIVE MEDICINES INITIATIVE
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
First IMI Ebola projects get underway
IMI is launching the first eight projects of its Ebola+ programme, covering vaccine development, manufacture and uptake as well as diagnostics.
- Read the press release
- 29/01/2015 : RT @EFPIA: READ new blog post from EFPIA DG on the fight to take doping out of sport @MagdaEfpia @wada_ama #AntiDopingPharma2015 http://t.c…
- 29/01/2015 : RT @CPathInstitute: The importance of cross consortia collaborations (see p. 12): http://t.co/yOhyfVTQAQ @BioCentury @IMI_JU #collab4cures
- 28/01/2015 : RT @EFPIA: @EFPIA launches new resources on speeding up the development of, and access to, new medicines. Find out more here: http://t.co/f…